Peptide Report
Semax Peptide Report
Catalog report for Semax, generated from Peptide Stacks product data and linked to the matching PeptideReports protocol page when available.
Current Price$29.99 – $50.00 CAD
Common Uses
People commonly use Semax for focus, mental clarity, motivation, and cognitive-performance routines, particularly during demanding work or study periods.
How It Works
Semax is an ACTH(4-10)-derived peptide analog. It is discussed for melanocortin-related signaling, neurotrophic-factor expression such as BDNF, and pathways tied to attention, stress resilience, and neuronal plasticity.
Storage
Powder form: In lyophilized powder form, Semax is generally kept sealed, dry, protected from direct light, and refrigerated unless the product label or certificate of analysis gives different handling instructions. Avoid leaving vials in hot rooms, vehicles, direct sunlight, or other temperature swings, because moisture, heat, and light are the main storage conditions people try to control before reconstitution.
Reconstituted: After reconstitution, Semax should generally be treated as more sensitive: keep it refrigerated, minimize unnecessary handling, avoid shaking, and use clean handling practices each time the vial is accessed. Follow the product label, protocol page, and any pharmacy or lab guidance for beyond-use timing; if the solution changes color, becomes cloudy, develops particles, or the vial integrity is questionable, it should not be used.
Protocol
The full Semax protocol is included below. The standalone protocol page remains available if you want to open it separately.
Open Standalone Protocol
Scope
Preparation examples, syringe conversion, community-reported patterns and important limitations.
Available strengths: 5 MG and 10 MG
Preparation Examples
These are calculation examples only. The concentration assumptions below are explicit so syringe units are never separated from vial strength and diluent volume.
| Setup |
Diluent |
Concentration |
Unit conversion |
| 5 MG vial – 2 mL example |
Add 2 mL bacteriostatic water |
2.5 mg/mL |
Each U-100 unit = 25 mcg |
| 10 MG vial – 2 mL example |
Add 2 mL bacteriostatic water |
5 mg/mL |
Each U-100 unit = 50 mcg |
Syringe Conversion
| Reported amount |
5 MG setup |
10 MG setup |
| 100 mcg |
4 units |
2 units |
| 200 mcg |
8 units |
4 units |
| 300 mcg |
12 units |
6 units |
| 600 mcg |
24 units |
12 units |
Always recalculate from the actual vial strength and diluent volume. A U-100 unit is 0.01 mL; it is not a dose by itself.
Community-Reported Patterns
| Recurring report |
Frequency seen |
Context in reports |
| 100-200 mcg |
Once or twice daily |
Lower-start reports |
| 300-600 mcg |
Daily total |
Most recurring range |
| 600 mcg or more |
Daily in cycles |
Higher experimental use |
Observations
- Community discussions most often centered on focus, motivation, cognition and neurological-recovery goals.
- The amount, frequency, route and cycle length varied substantially between reports.
- Reported outcomes were commonly confounded by diet, training, other products or existing treatment.
Caveats
- Most reports involve intranasal use; route and formulation materially affect exposure and cannot be interchanged.
- Community reports are uncontrolled anecdotes and do not establish an appropriate dose, safety, product identity, purity or efficacy.